IMO, if and when 113 shows results similar to the early Phase 1 results in 534,it could provide the big second leg up. they arent even putting a value on 113 right now...probably because its preclinical still. just when 534 was in early phase 1, they didnt give it any value..., now, the markets basically tacked on about 10.00 i value for pona.